Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with…
Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response rate through dual targeting of…
The gateway to professional audio starts at $34.9. SHENZHEN, China, May 27, 2025 /PRNewswire/ -- Hollyland, a leading provider of…